Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:291 (2 August), doi:10.1136/bmj.327.7409.291
| The first 150 words of the full text of this article appear below. |
EDITORHerbison et al made a plea for a more pragmatic approach to evaluating patients with an overactive bladder syndrome.1 A strong criticism of the work performed to date relates to the use of placebo as a control. They argue for the use of a behavioural approach such as bladder retraining as a comparator. This seems logical given that behavioural approaches are offered to most people with lower urinary tract symptoms (many of which will have overactive bladders) as a first line of treatment. Behavioural approaches might prove more effective for longer and lack the harms associated with pharmacotherapy.
We would not stop at bladder drill as one of the potential interventions.2 It could be that fluid scheduling, caffeine restriction, pelvic floor exercises, and the optimised management of comorbid conditions could all have a place in the management of the overactive bladder syndrome.3
4 In this respect it is interesting
Tim Lane, clinical lecturer in urological oncology
Department of Medical Oncology, St Bartholomew's Hospital, London E1A 7BE MrTMLane@aol.com
Christian Brown, research fellow
Clinical Effectiveness Unit, Royal College of Surgeons, London WC2A 3PE
Mark Emberton, senior lecturer
Institute of Urology, University College London, London W1P 7PN